Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Glioblastoma: Targeting the autophagy in tumorigenesis.

Yang K, Niu L, Bai Y, Le W.

Brain Res Bull. 2019 Nov;153:334-340. doi: 10.1016/j.brainresbull.2019.09.012. Epub 2019 Sep 30. Review.

PMID:
31580908
2.

TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells' invasion.

Zhang C, Zhang X, Xu R, Huang B, Chen AJ, Li C, Wang J, Li XG.

J Exp Clin Cancer Res. 2017 Nov 16;36(1):162. doi: 10.1186/s13046-017-0628-8.

3.

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS.

J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15.

4.

Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data.

Cheng HW, Liang YH, Kuo YL, Chuu CP, Lin CY, Lee MH, Wu AT, Yeh CT, Chen EI, Whang-Peng J, Su CL, Huang CY.

Cell Death Dis. 2015 May 7;6:e1753. doi: 10.1038/cddis.2015.77.

5.

miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.

Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, Wang K, Gao L, Qi ST, Lu YT.

J Hematol Oncol. 2018 May 29;11(1):70. doi: 10.1186/s13045-018-0618-0.

6.

Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.

Song WS, Yang YP, Huang CS, Lu KH, Liu WH, Wu WW, Lee YY, Lo WL, Lee SD, Chen YW, Huang PI, Chen MT.

J Chin Med Assoc. 2016 Oct;79(10):538-45. doi: 10.1016/j.jcma.2016.03.010. Epub 2016 Aug 13.

7.

Targeting Autophagy in Glioblastoma.

Noonan J, Zarrer J, Murphy BM.

Crit Rev Oncog. 2016;21(3-4):241-252. Review.

PMID:
27915974
8.

MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells.

Guo X, Xue H, Guo X, Gao X, Xu S, Yan S, Han X, Li T, Shen J, Li G.

Oncotarget. 2015 Dec 8;6(39):41620-37. doi: 10.18632/oncotarget.5871.

9.

CD164 regulates proliferation, progression, and invasion of human glioblastoma cells.

Wang CC, Hueng DY, Huang AF, Chen WL, Huang SM, Yi-Hsin Chan J.

Oncotarget. 2019 Mar 12;10(21):2041-2054. doi: 10.18632/oncotarget.26724. eCollection 2019 Mar 12.

10.

The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.

Galavotti S, Bartesaghi S, Faccenda D, Shaked-Rabi M, Sanzone S, McEvoy A, Dinsdale D, Condorelli F, Brandner S, Campanella M, Grose R, Jones C, Salomoni P.

Oncogene. 2013 Feb 7;32(6):699-712. doi: 10.1038/onc.2012.111. Epub 2012 Apr 23.

PMID:
22525272
11.

PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT.

Mecca C, Giambanco I, Bruscoli S, Bereshchenko O, Fioretti B, Riccardi C, Donato R, Arcuri C.

Front Cell Neurosci. 2018 Apr 10;12:99. doi: 10.3389/fncel.2018.00099. eCollection 2018.

12.

Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.

Raysi Dehcordi S, Ricci A, Di Vitantonio H, De Paulis D, Luzzi S, Palumbo P, Cinque B, Tempesta D, Coletti G, Cipolloni G, Cifone MG, Galzio R.

World Neurosurg. 2017 Sep;105:895-905. doi: 10.1016/j.wneu.2017.05.099. Epub 2017 May 27.

PMID:
28559081
13.

Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.

Palumbo S, Tini P, Toscano M, Allavena G, Angeletti F, Manai F, Miracco C, Comincini S, Pirtoli L.

J Cell Physiol. 2014 Nov;229(11):1863-73. doi: 10.1002/jcp.24640.

PMID:
24691646
14.

The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies.

Ryskalin L, Gaglione A, Limanaqi F, Biagioni F, Familiari P, Frati A, Esposito V, Fornai F.

Int J Mol Sci. 2019 Aug 5;20(15). pii: E3824. doi: 10.3390/ijms20153824. Review.

15.

Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells.

Melamed JR, Ioele SA, Hannum AJ, Ullman VM, Day ES.

Mol Pharm. 2018 Nov 5;15(11):5135-5145. doi: 10.1021/acs.molpharmaceut.8b00707. Epub 2018 Oct 11.

16.

Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.

Iglesia RP, Prado MB, Cruz L, Martins VR, Santos TG, Lopes MH.

Stem Cell Res Ther. 2017 Apr 17;8(1):76. doi: 10.1186/s13287-017-0518-1.

17.

Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma.

Caragher SP, Shireman JM, Huang M, Miska J, Atashi F, Baisiwala S, Hong Park C, Saathoff MR, Warnke L, Xiao T, Lesniak MS, James CD, Meltzer H, Tryba AK, Ahmed AU.

J Neurosci. 2019 Mar 13;39(11):1982-1993. doi: 10.1523/JNEUROSCI.1589-18.2018. Epub 2019 Jan 16.

18.

Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism, cell cycle, and survival.

Wang L, Shang Z, Zhou Y, Hu X, Chen Y, Fan Y, Wei X, Wu L, Liang Q, Zhang J, Gao Z.

Cell Death Dis. 2018 Feb 12;9(2):213. doi: 10.1038/s41419-017-0242-x.

19.

TDP-43/HDAC6 axis promoted tumor progression and regulated nutrient deprivation-induced autophagy in glioblastoma.

Lin TW, Chen MT, Lin LT, Huang PI, Lo WL, Yang YP, Lu KH, Chen YW, Chiou SH, Wu CW.

Oncotarget. 2017 May 18;8(34):56612-56625. doi: 10.18632/oncotarget.17979. eCollection 2017 Aug 22.

20.

Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy.

Spencer DA, Auffinger BM, Murphy JP, Muroski ME, Qiao J, Gorind Y, Lesniak MS.

Curr Cancer Drug Targets. 2017;17(3):236-254. doi: 10.2174/1568009616666161215161924. Review.

PMID:
27993114

Supplemental Content

Support Center